Company Update (NYSE:PFE): Pfizer, Lilly to resume late-stage study testing pain drug

[Reuters] – Pfizer Inc and Eli Lilly and Co said they planned to resume a late-stage study testing their pain drug tanezumab after the U.S. Food and Drug Administration lifted a partial hold . . . → Read More: Company Update (NYSE:PFE): Pfizer, Lilly to resume late-stage study testing pain drug Similar Articles: Company Update (NYSE:PFE): Pfizer, FDA in talks on prescription details for key breast cancer drug Stock Update (NYSE:PFE): FDA panel votes to keep severe warning on Pfizer anti-smoking drug Market Update: Pfizer Inc (NYSE:PFE) – FDA staff wants Pfizer to keep black box warning on anti-smoking drug